Brawn Biotech Ltd — Important, 14-10-2025: Company Update

Brawn Biotech announced its compliance with share transfer agent regulations for the quarter ending September 30. The company's Registrar and Share Transfer Agent confirmed that all securities received for dematerialisation were processed, accepted, or rejected, and subsequently listed on stock exchanges. Physical share certificates received for dematerialisation were properly cancelled, and the names of depositories were updated in the register of members within the stipulated timeframe. This ensures accurate and efficient processing of investor shareholdings, maintaining robust corporate governance and facilitating smooth trading for shareholders.